ARCHIVES

St. John’s Wort Not Indicated For Patients On Irinotecan

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

New Research Grant Awards

October 18, 1974

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

NCI Biostatistician Calls For Reanalysis Of Canadian Breast Screening Study

February 10, 1995

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

FCRF Recompetition Intriguing, Involved Various Possibility

May 9, 1986

Moves Forward With Approval From BSA

November 22, 2013